Income Taxes - Additional Information (Detail) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Income Tax Disclosure [Line Items] | ||
| Percentage Of Settlement Realized To Measure Tax Position | 50.00% | |
| Unrecognized tax benefits | $ 0 | $ 0 |
| Effective income tax rate reconciliation tax credit | 50.00% | 30.00% |
| Deferred tax assets operating loss carryforwards subject to expire | $ 1,000,000 | |
| Operating loss carryforwards expiration date | Dec. 31, 2037 | |
| Income tax expense benefit | $ 38,000 | $ (184,000) |
| Operating loss carryforwards limitations on use | The foreign NOL carryforwards can be carried forward indefinitely and used to offset up to 80% of future taxable income for future tax years. | |
| Domestic Tax Authority [Member] | ||
| Income Tax Disclosure [Line Items] | ||
| Operating loss carryforwards | $ 91,000,000 | 47,000,000 |
| Income tax expense benefit | 186,000 | |
| Operating loss carryforwards limitations on use | The remainder of the Company’s federal NOL carryforwards were generated beginning in 2018 and can be carried forward indefinitely and used to offset up to 80% of future taxable income for future tax years. As a result of the CARES Act, federal NOL carryforwards generated during 2018, 2019 and 2020 can be carried back five years and offset 100% of taxable income | |
| State and Local Jurisdiction [Member] | ||
| Income Tax Disclosure [Line Items] | ||
| Operating loss carryforwards | $ 76,000,000 | $ 48,000,000 |
| X | ||||||||||
- Definition Income tax disclosure. No definition available.
|
| X | ||||||||||
- Definition Percentage of settlement realized to measure tax position. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. No definition available.
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income. No definition available.
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|